Program:
11:00
Welcome and Introduction
RET Alterations in Thyroid Cancer
Chair: Lori Wirth, Massachusetts General
11:15
The Role of the Tumour Board/Multi-Disciplinary Team (MDT)
in Patient Management
Maria Cabanillas, MD Anderson
11:25
Case Studies from the Clinic
Jaume Capdevila, University Hospital Vall d'Hebron, Barcelona
11:45
Panel Discussion and Q&A
All panel
11:55
Symposium Closing Remarks
Chair: Lori Wirth, Massachusetts General
Symposium Objectives:
- Increase understanding of the types and impact of different RET alterations in Thyroid Cancer
- Discuss the optimal diagnostic techniques and guidelines to identify actionable biomarker driven Thyroid Cancer to support treatment decisions.
- Discuss the role of the Tumour Board / Multi-Disciplinary Team (MDT) in translating clinical evidence into clinical practice to optimize outcomes for Thyroid Cancer patients.
|